With 16 ETFs traded in the U.S. markets, Biotech ETFs gather total assets under management of $19.06B. The average expense ratio is 0.69%. Biotech ETFs can be found in the following asset classes:
The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF IBB with $9.23B in assets. In the last trailing year, the best performing Biotech ETF was the LABD at 203.56%. The most-recent ETF launched in the Biotech space was the Defiance NASDAQ Junior Biotechnology ETF IBBJ in 08/03/20.